MEI Pharma Inc. Stock
Pros and Cons of MEI Pharma Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MEI Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MEI Pharma Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 1.690% | -0.394% | -9.571% | -57.449% | -9.246% | -53.624% | -93.267% |
| Evolus Inc | -4.740% | -2.162% | -8.586% | -72.366% | -33.578% | -56.905% | -64.786% |
| Sangamo Therapeutics Inc. | -2.930% | 14.215% | -18.135% | -62.306% | 5.432% | -86.736% | -96.300% |
Comments
MEI Pharma (NASDAQ:MEIP) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat